FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

785960005: Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3769839012 Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3769840014 Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4524221000052111 karbidopa, vattenfritt (som karbidopa) 25 milligram och levodopa 250 milligram, munsönderfallande tablett sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet har täljarvärde som visar styrka 250 false Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet har täljarvärde som visar styrka 25 false Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has basis of strength substance (attribute) Levodopa (substance) true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has manufactured dose form Orodispersible tablet true Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet har nämnarvärde som visar styrka ett false Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet har nämnarvärde som visar styrka ett false Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has basis of strength substance (attribute) Carbidopa anhydrous true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet räkning av bas i aktiv ingrediens två false Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has precise active ingredient Carbidopa true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has precise active ingredient Levodopa (substance) true Inferred relationship Some 1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Is a Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) false Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Plays role Antiparkinson therapeutic role true Inferred relationship Some
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet Is a Product containing only carbidopa and levodopa in oral dose form (medicinal product form) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start